AlphaVax Human Vaccines Inc., of Durham, N.C., named Paula Myers Keith vice president of development, and Geoff Grishman director of business development and finance.

Catalytica Pharmaceuticals Inc., of Mountain View, Calif., appointed Tom Speace vice president of strategic partnering and business development.

Cephalon Inc., of West Chester, Pa., promoted Carl Savini to senior vice president, and named Roy Craig vice president of sales and Reinhard Koenig vice president, medical affairs.

Connetics Corp., of Palo Alto, Calif., appointed Gregory Vontz executive vice president and chief commercial officer.

Cypress Bioscience Inc., of San Diego, appointed to its board of directors Mark Rogers, president of Paramount Capital Investments, and Larry Kessel, a doctor with a private practice in internal and geriatric medicine.

Cytogen Corp., of Princeton, N.J., named Richard Krawiec vice president of investor relations and corporate communications.

Dendreon Corp., of Seattle, appointed to its board of directors Ruth Kunath, biotechnology portfolio manager for Vulcan Ventures Inc. The company also promoted Madhusduan Peshwa to vice president of process science.

Epitope Inc., of Beaverton, Ore., named Robert Thompson president and CEO.

GeneSolutions Inc., of Sunnyvale, Calif., named Mary Schramke vice president of marketing.

Genset, of Paris, hired James Kuo as vice president.

Genzyme Tissue Repair, of Cambridge, Mass., promoted Russell Herndon to president.

Human Genome Sciences Inc., of Rockville, Md., promoted Craig Rosen to executive vice president, research and development. In addition, the company promoted Fazal Khan to vice president, operations; Alain Cappeluti to vice president and controller; and Indrajit Sanyal to director, high-throughput biological screening.